<!DOCTYPE html PUBLIC "-//W3C//DTD XHTML 1.0 Strict//EN" "http://www.w3.org/TR/xhtml1/DTD/xhtml1-strict.dtd"><html xml:lang="en" lang="en" xmlns="http://www.w3.org/1999/xhtml"><head><meta http-equiv="Content-Type" content="text/html; charset=utf-8" /><meta name="ROBOTS" content="NOARCHIVE" /><meta name="googlebot" content="nosnippet" /><meta name="Document-Type" content="preparation" /><meta name="keywords" content="Levitra; Vardenafil" /><meta name="IX" content="Levitra; Vardenafil" /><title>Levitra®: British National Formulary</title><link type="text/css" rel="stylesheet" href="../../theme/theme.css" /><link type="text/css" rel="stylesheet" href="../../theme/print.css" media="print" /><link type="text/css" rel="stylesheet" href="59/style.css" /><link type="image/x-icon" rel="shortcut icon" href="favicon.ico" /><link rel="stylesheet" type="text/css" href="style/screen.css" media="screen" /><link rel="stylesheet" type="text/css" href="style/print.css" media="print" /><link rel="contents" type="text/html" href="index.htm" /><link rel="help" type="text/html" href="http://www.medicinescomplete.com/mc/help_page.htm" /><link rel="start" type="text/html" href="index.htm" title="British National Formulary" /><link rel="copyright" type="text/html" href="PHP0-publication-information.htm" title="Copyright information" /><link rel="bookmark" title="Skip Navigation" href="PHP5170-levitra.htm#pB" /><script type="text/javascript" src="https://ajax.googleapis.com/ajax/libs/jquery/1.7.0/jquery.min.js"></script><script type="text/javascript" src="../../scripts/jquery/jquery.tooltip.min.js"></script><script type="text/javascript" src="../../scripts/jquery/jquery.cookie.js"></script><script type="text/javascript" src="../../scripts/jquery/jquery.autosuggest.js"></script><script type="text/javascript" src="../../scripts/scripts.js"></script><style type="text/css">
  .contentsbox { position: fixed; z-index:1001;}
  .contentsbox_wrap {overflow:hidden;width:20px;height:130px; position:absolute;left:0;top:0;}
</style><!--[if lte IE 7]>
          <style type="text/css">
          .contentsbox {
          position: absolute;
          left: expression( ( 15 + ( ignoreMe2 = document.documentElement.scrollLeft ? document.documentElement.scrollLeft : document.body.scrollLeft ) ) + 'px' );
          top: expression( ( 250 + ( ignoreMe = document.documentElement.scrollTop ? document.documentElement.scrollTop : document.body.scrollTop) ) + 'px' );
          }
          .threecol_col3 {
          font-family: arial
          }
          .threecol_col3 a {
          font-family: verdana,helvetica,sans-serif
          }
          .threecol_col1 {
          font-family: arial
          }
          .threecol_col1 a {
          font-family: verdana,helvetica,sans-serif
          }
          div#pE {
          font-family: arial
          }
          div#pE a {
          font-family: verdana,helvetica,sans-serif
          }
          div#pK {
          font-family: arial
          }
          div#pK a {
          font-family: verdana,helvetica,sans-serif
          }
          </style>
          <![endif]--></head><body><?highlighter off?><div id="pU"><a id="pD" accesskey="s" rel="bookmark" href="PHP5170-levitra.htm#pB" title="Skip Navigation">Skip Navigation</a><img src="../../images/mylogo.png" alt="BNF.org Free Access" id="pI" /><ul id="pZ"><li><a href="http://www.medicinescomplete.com/mc/account.htm">You are signed in as a member of <b>BNF.org Free Access</b></a></li><li> | <a href="http://www.medicinescomplete.com/mc/login.htm">Sign in different user</a></li><li> | <a href="http://www.medicinescomplete.com/mc/logout.htm">Sign out</a></li></ul><a href="http://www.medicinescomplete.com/mc/" title="Go to the MedicinesComplete home page"><img src="../../images/mc.png" alt="MedicinesComplete" /></a><ul id="pM"><li><a href="http://www.medicinescomplete.com/mc/" class="selected" accesskey="1" title="Home: access key 1"><strong><span>Home</span></strong></a></li><li><a href="http://www.medicinescomplete.com/mc/marketing/current/"><strong><span>Welcome</span></strong></a></li><li><a href="http://www.medicinescomplete.com/mc/feedback.htm?pub=bnf&amp;uri=PHP5170-levitra.htm" accesskey="9" title="Feedback: access key 9"><strong><span>Feedback</span></strong></a></li><li><a href="http://www.medicinescomplete.com/mc/help.htm" accesskey="6" title="Help button: access key 6"><strong><span>Help</span></strong></a></li></ul></div><div id="pA"><div id="pY">British National Formulary</div><div id="pG">Printed from: Joint Formulary Committee.  <i>British National Formulary</i>. [online] London: BMJ Group and Pharmaceutical Press.. &lt; http://www.medicinescomplete.com/ &gt; [Accessed on 07 Oct 2012 (GMT)].</div><div id="pQ"><form id="searchForm" method="get" action="http://www.medicinescomplete.com/mc/bnf/current/search.htm"><fieldset><legend>Details</legend><label for="q">Search for</label><div id="qd"><div><input accesskey="4" type="text" id="q" name="q" /><input class="button" id="searchButton" type="submit" value="Search" name="searchButton" title="Search full text" /></div></div></fieldset></form><script type="text/javascript">$(document).ready(function(){$("#q").autoSuggest('http://www.medicinescomplete.com/mc/bnf/current/search/suggest.xml', {control: "#searchButton"});});</script></div></div><div id="pH"><div id="pN"><div id="pT"><span class="cA"><a href="http://www.medicinescomplete.com/mc/">Home</a></span> &gt; <a href="index.htm">BNF September 2012</a> &gt; <a href="PHP4758-obstetrics-gynaecology-and-urinary-tract-disorders.htm">7 Obstetrics, gynaecology, and urinary-tract disorders</a> &gt; <a href="PHP5031-drugs-for-genito-urinary-disorders.htm">7.4 Drugs for genito-urinary disorders</a> &gt; <a href="PHP5145-drugs-for-erectile-dysfunction.htm">7.4.5 Drugs for erectile dysfunction</a> &gt; <a href="PHP5154-phosphodiesterase-type-5-inhibitors.htm">Phosphodiesterase type-5 inhibitors</a> &gt; <a href="PHP5169-vardenafil.htm">VARDENAFIL</a></div><div id="pP"><div class="threecol_col1">◄ <a accesskey="[" href="PHP5167-tadalafil.htm" title="Previous: TADALAFIL">Previous page</a></div><div class="threecol_col2"> </div><div class="threecol_col3"><a accesskey="]" href="PHP5171-papaverine-and-phentolamine.htm" title="Next: Papaverine and phentolamine">Next page</a> ►</div></div></div></div><div id="p1"><div id="sideBar"><h2>See Also</h2><ul><li><h3>AHFS Drug Information</h3></li><li><a href="http://www.medicinescomplete.com/mc/ahfs/2010/a303041.htm" onclick="pageTracker._trackEvent('Related-Topic','Related-Click');">Vardenafil Hydrochloride</a><div class="breadcrumb"><p><strong>AHFS Drug Information</strong> &gt; Cardiovascular Drugs 24:00 &gt; Vasodilating Agents 24:12 &gt; Phosphodiesterase Type 5 Inhibitors 24:12.12</p></div></li></ul><ul><li><h3>Stockley's Interaction Alerts</h3></li><li><a href="http://www.medicinescomplete.com/mc/alerts/2010/20645-j.htm" onclick="pageTracker._trackEvent('Related-Topic','Related-Click');">Interactions of Vardenafil</a><div class="breadcrumb"><p><strong>Stockley's Interaction Alerts</strong> &gt; Interactants: V &gt; Interactions of Vardenafil</p></div></li></ul><ul><li><h3>British National Formulary (2)</h3></li><li><a href="PHP5154-phosphodiesterase-type-5-inhibitors.htm" onclick="pageTracker._trackEvent('Related-Topic','Related-Click');">Phosphodiesterase type-5 inhibitors</a><div class="breadcrumb"><p><strong>British National Formulary</strong> &gt; 7 Obstetrics, gynaecology, and urinary-tract disorders &gt; 7.4 Drugs for genito-urinary disorders &gt; 7.4.5 Drugs for erectile dysfunction</p></div></li><li><a href="PHP5169-vardenafil.htm" onclick="pageTracker._trackEvent('Related-Topic','Related-Click');">VARDENAFIL</a><div class="breadcrumb"><p><strong>British National Formulary</strong> &gt; 7 Obstetrics, gynaecology, and urinary-tract disorders &gt; 7.4 Drugs for genito-urinary disorders &gt; 7.4.5 Drugs for erectile dysfunction &gt; Phosphodiesterase type-5 inhibitors</p></div></li></ul><ul><li><h3>Clarke's Analysis of Drugs and Poisons</h3></li><li><a href="http://www.medicinescomplete.com/mc/clarke/2010/CLK-TD-c103-mn0001-mn0001.htm" onclick="pageTracker._trackEvent('Related-Topic','Related-Click');">Vardenafil</a><div class="breadcrumb"><p><strong>Clarke's Analysis of Drugs and Poisons</strong> &gt; Monographs &gt; Alphabetically &gt; V</p></div></li></ul><ul><li><h3>Martindale: The Complete Drug Reference</h3></li><li><a href="http://www.medicinescomplete.com/mc/martindale/2009/ms-20645-j.htm" onclick="pageTracker._trackEvent('Related-Topic','Related-Click');">Vardenafil</a><div class="breadcrumb"><p><strong>Martindale: The Complete Drug Reference</strong> &gt; Drugs and Ancillary Substances &gt; By therapeutic use &gt; Urological Drugs &gt; Drug Monographs</p></div></li></ul><ul><li><h3>The Merck Index</h3></li><li><a href="http://www.medicinescomplete.com/mc/merck/2010/09935.htm" onclick="pageTracker._trackEvent('Related-Topic','Related-Click');">Vardenafil</a><div class="breadcrumb"><p><strong>The Merck Index</strong> &gt; Monographs &gt; V &gt; VA</p></div></li></ul><ul><li><h3>Stockley's Drug Interactions</h3></li><li><a href="http://www.medicinescomplete.com/mc/stockley/2010/int-E2E0E2E3E0R0D106.htm" onclick="pageTracker._trackEvent('Related-Topic','Related-Click');">Interactions of Vardenafil</a><div class="breadcrumb"><p><strong>Stockley's Drug Interactions</strong> &gt; Interactants, Alphabetically &gt; V</p></div></li></ul><script type="text/javascript" src="scripts/sidebar.js"></script></div><div id="pB"><h1>VARDENAFIL</h1><?highlighter on?><div id="pC" class="jN"><div class="cL"><div class="cE"><h3 class="cO">Additional information</h3> <p class="cT"> interactions (<a href="bnf_int967-vardenafil.htm">Vardenafil</a>).</p></div></div><div class="cL"><div class="cE"><h2 class="cN">Indications </h2> <p class="cT">erectile dysfunction</p></div> </div> <div class="cL"><div class="cE"><h2 class="cN">Cautions </h2> <p class="cT">see <a title="target-block: Phosphodiesterase type 5 inhibitor cautions" href="PHP5154-phosphodiesterase-type-5-inhibitors.htm#PHP5155">notes above</a>; also elderly; bleeding disorders or active peptic ulceration; susceptibility to prolongation of QT interval (including concomitant use of drugs which prolong QT interval); <strong>interactions:</strong> Appendix 1 (vardenafil)</p></div> </div> <div class="cL"><div class="cE"><h2 class="cN">Contra-indications </h2> <p class="cT">see <a title="target-block: Phosphodiesterase type 5 inhibitor contra-indications" href="PHP5154-phosphodiesterase-type-5-inhibitors.htm#PHP5156">notes above</a>; also hereditary degenerative retinal disorders</p></div> </div> <div class="cL"><div class="cE"><h2 class="cN">Hepatic impairment </h2> <p class="cT">initial dose 5 mg in mild to moderate impairment, increased subsequently according to response (max. 10 mg in moderate impairment); manufacturer advises avoid in severe impairment</p></div> </div> <div class="cL"><div class="cE"><h2 class="cN">Renal impairment </h2> <p class="cT">initial dose 5 mg if eGFR less than 30 mL/minute/1.73 m<sup>2</sup></p></div> </div> <div class="cL"><div class="cE"><h2 class="cN">Side-effects </h2> <p class="cT">see <a title="target-text: Phosphodiesterase type-5 inhibitors side-effects - notes" href="PHP5154-phosphodiesterase-type-5-inhibitors.htm#PHP5161">notes above</a>; also <em>less commonly</em> drowsiness, dyspnoea, increased lacrimation, photosensitivity; <em>rarely</em> anxiety, transient amnesia, hypertonia, and raised intra-ocular pressure</p></div> </div> <div class="cL"><h2 class="cM">Dose</h2><div class="cR"><ul><li><p>See under preparations</p></li> </ul></div></div> </div><div id="pS"><p>Sub-sections</p><div id="PHP5170-levitra" style="margin: 0 0 0 20px;"><h1 class="title"><span><cite><a href="PHP5170-levitra.htm#ID0EADDAA" class="tooltip ID0EADDAA">(1)</a></cite></span>Levitra® <span>(<a href="PHP10005-index-of-manufacturers.htm#PHP10055">Bayer</a>)</span><span> <img src="images/pom_l.png" alt="Prescription only medicine" /> <img src="images/notnhs_l.png" alt="Not prescribable under National Health Service (NHS)" /></span></h1><div class="cU"><p><strong>Tablets</strong>, all orange, f/c, vardenafil (as hydrochloride trihydrate) 5 mg, net price 4-tab pack = £7.56, 8-tab pack = £15.12; 10 mg, 4-tab pack = £14.08, 8-tab pack = £28.16; 20 mg, 4-tab pack = £23.48, 8-tab pack = £46.96</p><p class="cR"><strong>Dose </strong><span class="cP">adult</span> over 18 years, initially 10 mg (patients on alpha-blocker therapy 5 mg) approx. 25–60 minutes before sexual activity, subsequent doses adjusted according to response up to max. 20 mg as a single dose; max. 1 dose in 24 hours </p><div class="cG"><div class="cE"><h3 class="cT">Note</h3> <p class="cT"> Onset of effect may be delayed if taken with high-fat meal</p></div></div></div><div class="cU"><p><strong>Orodispersible tablets</strong>, vardenafil (as hydrochloride) 10 mg, net price 4–tab pack = £17.88</p><p class="cR"><span class="cAD">Excipients </span>include aspartame</p><p class="cR"><strong>Dose </strong><span class="cP">adult</span> over 18 years, 10 mg approx. 25–60 minutes before sexual activity; max. 10 mg in 24 hours (dose form not suitable for patients with moderate hepatic impairment, or for initiation of therapy in patients taking alpha-blockers, or if eGFR less than 30 mL/minute/1.73m<sup>2</sup>)</p><p class="cR">The <a title="BNF:target-block: NICE and Scottish Medicines Consortium" href="PHP60-general-guidance.htm#PHP70"><em>Scottish Medicines Consortium</em></a> has advised (September 2011) that vardenafil orodispersible tablets (<em>Levitra</em>®) are accepted for restricted use within NHS Scotland for men for whom an orodispersible tablet is an appropriate formulation.</p><div class="cF"><div class="cE"><h3 class="cT">Important</h3> <p class="cT"><em>Levitra® 10 mg orodispersible</em> tablets and<em> Levitra® 10 mg film coated tablets</em> are <strong>not</strong> bioequivalent</p></div></div></div></div></div><?highlighter off?><div id="pE">◄ <a accesskey="[" href="PHP5167-tadalafil.htm">Previous: TADALAFIL</a> | <a class="top" href="PHP5170-levitra.htm#">Top</a> | <a accesskey="]" href="PHP5171-papaverine-and-phentolamine.htm">Next: Papaverine and phentolamine</a> ►</div><ol class="cC"><li class="footnote" id="ID0EADDAA"><p><img src="images/notnhs_s.png" alt="Prescription-only medicines" /> except to treat erectile dysfunction in men who:</p><ul><li><p>have diabetes, multiple sclerosis, Parkinson's disease, poliomyelitis, prostate cancer, severe pelvic injury, single gene neurological disease, spina bifida, or spinal cord injury;</p> </li><li><p>are receiving dialysis for renal failure;</p> </li><li><p>have had radical pelvic surgery, prostatectomy (including transurethral resection of the prostate), or kidney transplant;</p> </li><li><p>were receiving <em>Caverject</em>®, <em>Erecnos</em>®, <em>MUSE</em>®, <em>Viagra</em>®, or <em>Viridal</em>® for erectile dysfunction, at the expense of the NHS, on 14 September 1998;</p> </li><li><p>are suffering severe distress as a result of impotence (prescribed in specialist centres only, see notes above).</p> </li></ul><p>The prescription must be endorsed ‘SLS’.</p></li></ol></div></div><div id="pF"><div id="pL"><div id="footer"><div id="footerinner"><ul><li><a accesskey="0" href="accessibility.htm" title="Accessibility information: access key 0">Accessibility</a> | </li><li><a href="http://www.medicinescomplete.com/mc/marketing/current/contact.htm">Contact Us</a> | </li><li><a href="privacy.htm" title="Cookie and Privacy Policy">Cookie and Privacy Policy</a> | </li><li><a accesskey="3" href="http://www.medicinescomplete.com/mc/sitemap.htm" title="Site Map: access key 3">Site Map</a> | </li><li><a accesskey="8" href="terms.htm" title="Terms and Conditions: access key 8">Terms and Conditions</a></li></ul></div></div></div><div id="pX"><p><a href="PHP0-publication-information.htm" rel="copyright">Copyright © BMJ Group and Pharmaceutical Press 2012. All rights reserved. </a></p></div></div><script type="text/javascript">$(document).ready(function(){$.ga('UA-9959526-1');});</script></body></html>